ArticleInternational journal of epidemiology2026
Prenatal fluoride exposure and pregnancy outcomes in two US pregnancy cohorts.
Article in International journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundOur goal was to evaluate the relationship between prenatal fluoride exposure and pregnancy outcomes.
methodsWe measured urinary fluoride collected during the second trimester among pregnant people recruited from California and Illinois from 2014 to 2020 (N = 949). We evaluated risk differences (RDs) of preterm birth (PTB), small-for-gestational age (SGA), large-for-gestational age (LGA), gestational diabetes, and differences in birthweight, birthweight-for-gestational age z-scores, and gestational age associated with a 0.1 mg/l increase in fluoride using linear regression to estimate effects on the additive scale. We also used modified treatment policies with machine learning to estimate the effects of hypothetical interventions to reduce urinary fluoride by 0.1 and 0.5 mg/l on pregnancy outcomes. In the Illinois cohort, we estimated effects by trimester.
resultsIn our main analyses, we found no associations between urinary fluoride levels and pregnancy outcomes. For instance, for a 0.1 mg/l increase in fluoride, we saw no change in the risk of PTB, SGA, or gestational diabetes. We also found no differences associated with hypothetical reductions of prenatal fluoride by 0.1 mg/l or 0.5 mg/l for any outcomes. In the trimester-specific analyses for Illinois participants, we found increased LGA risk during the first (RD = 0.004, 95% CI -0.001, 0.009) and third trimesters (RD = 0.007, 95% CI 0.001, 0.012), and reduced LGA risk during the second trimester (RD = -0.006, 95% CI -0.011, 0.000), associated with 0.1 mg/l higher urinary fluoride.
conclusionsPrenatal fluoride exposure does not appear to affect pregnancy outcomes, but preliminary evidence suggests that higher fluoride levels may affect the risk of LGA depending on timing of exposure during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.